Vedere Bio

0 followers

‌

Vedere Bio II, Inc.® is a company developing next generation ocular gene therapies designed for vision restoration and preservation for patients with vision loss due to photoreceptor death.

Industries

Headquarters

Stage

Employees

Links

Org chart

Cyrus D. Mozayeni

Co-Founder, President & CEO

Cyrus D. Mozayeni

Collapse

Mark Gaffney

COO

Gina Consylman

CFO

Mike Murtagh

SVP, Regulatory Affairs

Martina Schinke

VP, Program Leader

Daniel Zimmer

Senior Director, Program Lead

Ellen Zyrkowski

Associate Director, HR & Communications

Soraya Bekkali, MD

Non Executive Director

Xiaozhi Ren (任小峙) Ph.D.

Director, CMC, Cell Line and Process Development

Karen Guerin

Senior Director, Discovery Research

Teams

Leadership Team

8 members

CEO and Executive Team

3 members

Founding Team

3 members

Board of Directors

2 members

Similar companies

BioMarin Pharmaceutical

22 followers

Adaptive Biotechnologies

11 followers

Agilent Technologies

60 followers

Regeneron

77 followers

Verve Therapeutics

53 followers

Discover companies